Nexien BioPharma And Ivy League University Medical School Collaborate On Pre-Clinical Cannabinoid Studies
Partnership Will Investigate Advanced Parenteral Cannabinoid-Based Formulations For Acute Treatment of Convulsive Disorders DENVER, Colo., Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nexien BioPharma Inc. (OTC QB: NXEN) (“Nexien” or the “Company …